A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK-0873 in Patients With COPD
Phase of Trial: Phase II/III
Latest Information Update: 26 Apr 2017
At a glance
- Drugs MK 0873 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 25 Apr 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 10 Nov 2009 Actual number of patients (604) added as reported by ClinicalTrials.gov.
- 10 Nov 2009 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.